# Metformin in the Diastolic Dysfunction of Metabolic Syndrome

> **NCT02017561** · PHASE2 · COMPLETED · sponsor: **Universidade do Porto** · enrollment: 54 (actual)

## Conditions studied

- Metabolic Syndrome X
- Diastolic Dysfunction
- Insulin Resistance

## Interventions

- **BEHAVIORAL:** Lifestyle Counseling
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT02017561
- **Lead sponsor:** Universidade do Porto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2020-03-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02017561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02017561, "Metformin in the Diastolic Dysfunction of Metabolic Syndrome". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02017561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*